These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 17673648)
1. Building an HIV-proof immune system. Cohen J Science; 2007 Aug; 317(5838):612-4. PubMed ID: 17673648 [No Abstract] [Full Text] [Related]
2. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model. ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146 [TBL] [Abstract][Full Text] [Related]
7. Novel HIV therapeutic strategies. MacDougall DS J Int Assoc Physicians AIDS Care; 1997 Mar; 3(3):9-11, 14. PubMed ID: 11364128 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell-based gene therapy against HIV infection: promises and caveats. van Griensven J; De Clercq E; Debyser Z AIDS Rev; 2005; 7(1):44-55. PubMed ID: 15875660 [TBL] [Abstract][Full Text] [Related]
9. HIV vector-mediated targeted suicide gene therapy for adult T-cell leukemia. Miyake K; Inokuchi K; Miyake N; Dan K; Shimada T Gene Ther; 2007 Dec; 14(23):1662-7. PubMed ID: 17898798 [TBL] [Abstract][Full Text] [Related]
10. [Possibility of immunotherapy against HIV infection]. Matsushita S Tanpakushitsu Kakusan Koso; 2001 Apr; 46(5):638-43. PubMed ID: 11296361 [No Abstract] [Full Text] [Related]
11. Immune reconstitution inflammatory syndrome of the small bowel in a human immunodeficiency virus-negative patient. Daum S; Loddenkemper C; Schneider T Clin Gastroenterol Hepatol; 2007 Jul; 5(7):e27-8. PubMed ID: 17628330 [No Abstract] [Full Text] [Related]
12. HIV treatment to be tested in patients. Mol Ther; 2004 Jul; 10(1):3. PubMed ID: 15272472 [No Abstract] [Full Text] [Related]
14. MazF-expressing T cells could suppress HIV replication. Immunotherapy; 2011 Mar; 3(3):310. PubMed ID: 21520506 [No Abstract] [Full Text] [Related]
15. The immunopathogenesis of HIV infection. Rosenberg ZF; Fauci AS Adv Immunol; 1989; 47():377-431. PubMed ID: 2573256 [No Abstract] [Full Text] [Related]
16. A vaccine that delivers rather than induces antibodies. Letvin NL Gene Ther; 2009 Nov; 16(11):1283-4. PubMed ID: 19759565 [No Abstract] [Full Text] [Related]
17. B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design. Cagigi A; Nilsson A; De Milito A; Chiodi F Vaccine; 2008 Jun; 26(24):3016-25. PubMed ID: 18164520 [TBL] [Abstract][Full Text] [Related]
18. Host genetic factors that control immune responses to retrovirus infections. Miyazawa M; Tsuji-Kawahara S; Kanari Y Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203 [TBL] [Abstract][Full Text] [Related]
19. How doctors are re-engineering the immune system to fight HIV infection. Roehr B BMJ; 2011 Mar; 342():d1373. PubMed ID: 21363862 [No Abstract] [Full Text] [Related]
20. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient. Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]